259 related articles for article (PubMed ID: 22872710)
1. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.
Mantha S; Karp R; Raghavan V; Terrin N; Bauer KA; Zwicker JI
BMJ; 2012 Aug; 345():e4944. PubMed ID: 22872710
[TBL] [Abstract][Full Text] [Related]
2. Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis.
Glisic M; Shahzad S; Tsoli S; Chadni M; Asllanaj E; Rojas LZ; Brown E; Chowdhury R; Muka T; Franco OH
Eur J Prev Cardiol; 2018 Jul; 25(10):1042-1052. PubMed ID: 29745237
[TBL] [Abstract][Full Text] [Related]
3. Progestin-only contraception and thromboembolism: A systematic review.
Tepper NK; Whiteman MK; Marchbanks PA; James AH; Curtis KM
Contraception; 2016 Dec; 94(6):678-700. PubMed ID: 27153743
[TBL] [Abstract][Full Text] [Related]
4. Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.
Visser J; Snel M; Van Vliet HA
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD003990. PubMed ID: 23543528
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins Long S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009849. PubMed ID: 26195091
[TBL] [Abstract][Full Text] [Related]
7. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
8. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study.
Byrne EH; Anahtar MN; Cohen KE; Moodley A; Padavattan N; Ismail N; Bowman BA; Olson GS; Mabhula A; Leslie A; Ndung'u T; Walker BD; Ghebremichael MS; Dong KL; Kwon DS
Lancet Infect Dis; 2016 Apr; 16(4):441-8. PubMed ID: 26723758
[TBL] [Abstract][Full Text] [Related]
9. Weight change at 12 months in users of three progestin-only contraceptive methods.
Vickery Z; Madden T; Zhao Q; Secura GM; Allsworth JE; Peipert JF
Contraception; 2013 Oct; 88(4):503-8. PubMed ID: 23582238
[TBL] [Abstract][Full Text] [Related]
10. The relationship between progestin hormonal contraception and depression: a systematic review.
Worly BL; Gur TL; Schaffir J
Contraception; 2018 Jun; 97(6):478-489. PubMed ID: 29496297
[TBL] [Abstract][Full Text] [Related]
11. Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.
Cohen MA; Edelman A; Paynter R; Henderson JT
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014908. PubMed ID: 36622724
[TBL] [Abstract][Full Text] [Related]
12. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Truitt ST; Fraser AB; Grimes DA; Gallo MF; Schulz KF
Cochrane Database Syst Rev; 2003; (2):CD003988. PubMed ID: 12804497
[TBL] [Abstract][Full Text] [Related]
13. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
14. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
Han L; Jensen JT
Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
[TBL] [Abstract][Full Text] [Related]
15. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
[TBL] [Abstract][Full Text] [Related]
16. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.
Gourdy P; Bachelot A; Catteau-Jonard S; Chabbert-Buffet N; Christin-Maître S; Conard J; Fredenrich A; Gompel A; Lamiche-Lorenzini F; Moreau C; Plu-Bureau G; Vambergue A; Vergès B; Kerlan V
Ann Endocrinol (Paris); 2012 Nov; 73(5):469-87. PubMed ID: 23078975
[TBL] [Abstract][Full Text] [Related]
18. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
[TBL] [Abstract][Full Text] [Related]
19. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
20. Effect of oral contraceptive progestins on serum copper concentration.
Berg G; Kohlmeier L; Brenner H
Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
